rgdfk peptide Peptide - revox-multi-peptide-serum peptides Understanding the RGDfK Peptide: A Powerful Tool in Biomedical Research and Therapeutics

calcitonin-gene-related-peptide-receptor-antagonists The RGDfK peptide, a cyclic peptide sequence, has emerged as a significant molecule in various biomedical applications, particularly in the realms of cancer research, targeted drug delivery, and tissue engineering.c(RGDfK) | C27H41N9O7 | CID 22134127 - PubChem - NIH This peptide is characterized by its specific binding affinity to integrins, a class of cell surface receptors crucial for cell adhesion, migration, and proliferation. The RGDfK motif, comprised of Arginine (R), Glycine (G), Aspartic acid (D), D-Phenylalanine (f), and Lysine (K), plays a pivotal role in this interaction.

The Science Behind RGDfK Peptide's Efficacy

The fundamental mechanism driving the utility of the RGDfK peptide lies in its potent and selective inhibition of integrins, most notably the αvβ3 integrin.Cyclo (RGDfK) (CAS 161552-03-0) This integrin is frequently overexpressed on the surface of tumor cells and neovascular blood vessels, making it an attractive target for therapeutic interventionsThe cyclicpeptidec(RGDfK) was built on solid support by standard Fmoc-based solid-phasepeptidesynthesis [28, 29] and modified with TCO in solution after .... Studies have demonstrated that Cyclo(-RGDfK) exhibits a remarkable IC50 of 0.94 nM for αvβ3 integrin, highlighting its high affinity and specificityCyclo (RGDfK) (CAS 161552-03-0). Furthermore, the cyclic nature of the RGDfK peptide enhances its protease resistance and stability in aqueous solutions, contributing to its sustained biological activityCyclo (-RGDfK) | αvβ3 integrin inhibitor | Buy from Supplier ....

The RGDfK peptide is not merely a standalone entity; it can be modified and integrated into various platforms to enhance its therapeutic potential. For instance, it has been successfully conjugated to DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) for radiolabeling, enabling molecular imaging of breast cancer and other malignancies. The ability to label the peptide with 125I or 99mTc allows for precise visualization and quantification of tumor sites in vivo. Research has also explored the synthesis of monomeric, dimeric, and tetrameric c[RGDfK] dendrimers, showcasing the versatility in creating multivalent constructs with potentially amplified therapeutic effects.

Applications in Cancer Research and Therapy

The overexpression of αvβ3 integrin on tumor vasculature makes RGDfK peptide-based strategies highly promising for targeting tumor cells and their supporting blood supplyRGD peptide in cancer targeting: Benefits, challenges, solutions, and .... The RGDfK peptide can be utilized to deliver therapeutic agents directly to the tumor microenvironment, thereby minimizing systemic toxicity. This targeted approach is a cornerstone of modern cancer treatment, aiming to improve efficacy while reducing side effects.

Beyond direct therapeutic delivery, RGDfK peptide plays a crucial role in cancer targeting. Its ability to bind specifically to receptors on neovascular blood vessels of various human cancers has been extensively documented. This characteristic makes it an invaluable tool for diagnostic imaging, allowing for early detection and precise staging of the disease. The molecular imaging of breast cancer using RGD peptides is a testament to their diagnostic capabilities.

Advancements in Tissue Engineering and Cell Adhesion

The role of RGDfK peptide extends beyond oncology. In tissue engineering, peptide-based ECM mimics are employed to improve cellular interactions with biomaterials. The Cyclo(RGDfK) peptide has been shown to enhance human pluripotent stem cell (hPSC) adhesion and proliferation on synthetic surfaces, paving the way for more effective regenerative medicine applications. For instance, Cyclo(RGDfK) peptide functionalized polymeric nanocarriers are being developed for targeted delivery and improved cellular interactions.

The formation of precise molecular gradients of cyclicRGDfK peptide patches on substrates, achieved through modified substrate dip-coating processes, further underscores its utility in controlling cell behavior and promoting specific cellular responses. This is critical for creating environments that mimic the natural extracellular matrix, thereby facilitating tissue regeneration.

Synthesis and Chemical Properties

The synthesis of RGDfK peptide typically involves solid-phase peptide synthesis (SPPS) techniques.Cyclo(RGDfK). Write a review to earn BioPoints. The cyclic pentapeptide cyclo ...PeptideServices;PeptideOverview ·PeptideManufacture · CustomPeptide... The original synthesis of cRGDfK employed Fmoc (9-fluorenylmethyloxycarbonyl) solid-phase chemistry.Cyclo(-RGDfK) Supplier | CAS 161552-03-0 The resulting linear, protected RGDfK peptide is then cleaved from the solid resinDiagNano™ NOTA-c(RGDfK) Peptide Conjugated CdSSe .... The cyclic structure is formed through cyclization, often achieved on a solid support or in solution.Cyclo (RGDfK) (CAS 161552-03-0) The molecular formula of c(RGDfK) is C27H41N9O7, with a molecular weight of approximately 603.7 g/mol. The CAS number for c(RGDfK) is 161552-03-0.

The RGDfK peptide is generally stored lyophilized at -20°C and kept desiccated to maintain its stability.The relationship between the cyclic-RGDfK ligand and ... In lyophilized form, it can remain stable for up to 36 months. In solution, its stability is reduced, necessitating appropriate storage conditions.

Future Directions and Ongoing Research

The ongoing research into RGDfK peptide and its derivatives continues to push the boundaries of biomedical innovation.The original synthesis of cRGDfK employed the Fmoc solid-phase chemistry to build a linear, protectedRGDfK peptide, followed by cleavage from the solid resin, ... Studies are exploring the structure-activity relationships of RGD-containing peptides to optimize their binding affinity and therapeutic efficacy.作者：HP Sondermeijer·2018·被引用次数：35—CyclicRGDfK peptideis protease resistant, highly stable in aqueous solutions, and has high affinity for cellular integrins. Cyclic RGDfK-modified alginate ... The development of novel RGD peptide conjugates, such as those utilizing PEG4-c(RGDfK), aims to improve pharmacokinetic profiles and enhance targeting capabilities.Cyclo(-RGDfK) is a potent and selective inhibitor of the αvβ3 integrin, with an IC50 of 0.94 nM. Cyclo(-RGDfK) TFA potently targets tumor microvasculature ...

The exploration of self-assembled nanoparticles based on the c(RGDfk) motif offers a promising avenue for developing biodegradable, tumor-targeted drug delivery systems. As our understanding of integrin biology and peptide chemistry deepens, the RGDfK peptide is poised to play an even more critical role in the development of next-generation diagnostics and therapeutics.作者：L Liu·2014·被引用次数：35—In this study, biodegradable, tumor-targeted, self-assembledpeptidenanoparticles consisting of cyclo(Arg–Gly–Asp–d–Phe–Lys)-8–amino–3,6–dioxaoctanoic acid–